Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

FSZ vs FGM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FSZ Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

FSZ Overall Winner 6-Pillar Tally: FSZ 0 – 0 FGM (6 Tie) Matrix Metrics: FSZ 3 – 0 FGM

As of Nov 16, 2026, FSZ (FSZ) is the stronger overall head-to-head candidate over First Trust Germany AlphaDEX Fund (FGM) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FSZ carries a Unified Composite Score of 39.8/100 (SELL) at $81.66 (N/M Forward P/E, N/A operating margin), whereas FGM carries 36.6/100 (SELL) at $58.26 (N/M Forward P/E, N/A operating margin).

  • Defensive Composite Rating Caution: Although FSZ compares more favorably head-to-head, both FSZ (39.8/100 SELL) and FGM (36.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FSZ vs FGM
FSZ US Equity Head-to-Head Winner
FSZ
Institutional Equity
$81.66
-0.79% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.74β · 17% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 47.0 Fund 43.0 Flow 50.0 Mom 16.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.1 · SMA20: $82.03 · SMA50: $80.17
FGM NASDAQ
First Trust Germany AlphaDEX Fund
Institutional Equity
$58.26
-1.29% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.04β · 21% Vol
Unified Composite Score
36.6 / 100 SELL
Tech 45.0 Fund 47.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.2 · SMA20: $58.33 · SMA50: $59.48

6-Pillar Scorecard Institutional Category Breakdown (FSZ 0 – 0 FGM)

Columns: Metric · FSZ · FGM
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 114.2% (50th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FSZ (3) vs FGM (0)
Institutional Metric FSZ FGM Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
57% ($75–$86) 21% ($55–$71) Stronger Trend FSZ
Beta / 30D Volatility
Risk Regime
0.74β · 17% Vol 1.04β · 21% Vol Lower Realized Risk FSZ
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 36.6 / 100 (SELL) Higher Composite FSZ
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FSZ +1.7 pp
FSZ: +2.23% · FGM: +0.53%
3M Horizon FSZ +6.41 pp
FSZ: -0.44% · FGM: -6.85%
6M Horizon FSZ +10.66 pp
FSZ: +0.73% · FGM: -9.93%
1Y Horizon FSZ +5.96 pp
FSZ: +4.41% · FGM: -1.55%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FSZ vs FGM. Trailing 12-month operating profitability (FSZ N/A vs FGM N/A) and valuation multiples (FSZ N/M vs FGM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

FSZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
FGM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FSZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 114.2%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FSZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FGM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FGM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FSZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
FGM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ FSZ vs FGM Key Questions & Quantitative Answers

As of Nov 16, 2026, FSZ (FSZ) is the stronger overall head-to-head candidate over First Trust Germany AlphaDEX Fund (FGM) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FSZ carries a Unified Composite Score of 39.8/100 (SELL) at $81.66 (N/M Forward P/E, N/A operating margin), whereas FGM carries 36.6/100 (SELL) at $58.26 (N/M Forward P/E, N/A operating margin). Defensive Composite Rating Caution: Although FSZ compares more favorably head-to-head, both FSZ (39.8/100 SELL) and FGM (36.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

FSZ and FGM split Growth & Scale metrics: FSZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with FGM at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, FSZ generates N/A in USD-normalized revenue versus N/A for FGM. In operating R&D and SG&A reinvestment, FSZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FGM.

FSZ and FGM trade at balanced relative valuation multiples. FSZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas FGM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FSZ (N/A ROE) versus FGM (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, FSZ carries 114.2% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.74β · 17% Vol realized risk). By comparison, FGM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.